BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28647210)

  • 1. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
    Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
    Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
    Wu H; Zhang J; Dai R; Xu J; Feng H
    J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
    Zhu H; Cai H; Tang M; Tang J
    Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 Expression Together with VEGF can be a Predictor for Lung Metastasis and Poor Prognosis in Osteosarcoma.
    Mohamed FEA; Khalil EZI; Toni NDM
    Pathol Oncol Res; 2020 Jul; 26(3):1787-1795. PubMed ID: 31676993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.
    Yu D; Lv F; Zhang J; Li H
    Ann Clin Lab Sci; 2016 Sep; 46(5):508-14. PubMed ID: 27650618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
    Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
    BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
    Zhao H; Wu Y; Chen Y; Liu H
    Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
    Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
    BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
    J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
    Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
    Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.